CD274 and cancer: The EBV-positive subgroup showed distinctive molecular characteristics, including, but not limited to, the highest hypermethylation rates in the host DNA [6] compared to other cancers, frequent mutations in the PIK3CA, JAK2, and CD274 (PD-L1) genes [7], and deletions in key tumor suppressor genes.